SCHEMBL4334897

SCHEMBL4334897

N=C(N)N[C@H](CNC(=O)C(F)(F)F)CC1CCCCC1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 5/20 0.34
HDAC3 O15379 2/20 0.34
HDAC4 P56524 2/20 0.34
HDAC1 Q13547 1/20 0.34
MLYCD O95822 1/20 0.33
CTSD P07339 2/20 0.33
MC4R P32245 1/20 0.33
MC3R P41968 1/20 0.33
F2 P00734 1/20 0.33
F2RL1 P55085 1/20 0.32
METAP2 P50579 2/20 0.32
METAP1 P53582 1/20 0.32
CTSS P25774 1/20 0.32
CTSK P43235 1/20 0.32
REN P00797 1/20 0.32
CPB2 Q96IY4 1/20 0.31
CHRNB2 P17787 1/20 0.31
CHRNB4 P30926 1/20 0.31
CHRNA3 P32297 1/20 0.31
CHRNA4 P43681 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL2074360 0.76 SCNN1A (0.35) F2
SCHEMBL4334976 0.76 EPHX1 (0.38) MEN1KMT2A
SCHEMBL4324192 0.73 EPHX1 (0.39) MEN1KMT2A
SCHEMBL4335002 0.73 EPHX1 (0.39) MEN1KMT2A
SCHEMBL2075553 0.73 SCNN1A (0.38) TSHRKMT2A
Trifluoroacetic Acid SCHEMBL4334895 0.73 MMP1 (0.42) F2CTSSCTSKCPB2
SCHEMBL12649027 0.71 CTSK (0.49) CTSSCTSKKMT2A
SCHEMBL12076319 0.69 MBOAT4 (0.31) F2METAP2METAP1REN
SCHEMBL12649025 0.69 ANPEP (0.40) RENMEN1KMT2A
SCHEMBL4331063 0.69 HPGDS (0.46) CTSSCTSKCPB2CHRNB2CHRNB4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8664228-B2 3,5-diamino-6-chloro-pyrazine-2-carboxylic acid derivatives and their use as epithelial sodium channel blockers for the treatment of airway diseases NOVARTIS AG (CH) 2014-03-04 US disclosed
EP-2285785-B1 3,5-DIAMINO-6-CHLORO-PYRAZINE-2-CARBOXYLIC ACID DERIVATIVES AND THEIR USE AS EPITHELIAL SODIUM CHANNEL BLOCKERS FOR THE TREATMENT OF ARWAY DISEASES NOVARTIS AG (CH) 2012-09-05 EP disclosed
WO-2009138378-A1 3,5-DIAMINO-6-CHLORO-PYRAZINE-2-CARBOXYLIC ACID DERIVATIVES AND THEIR USE AS EPITHELIAL SODIUM CHANNEL BLOCKERS FOR THE TREATMENT OF ARWAY DISEASES NOVARTIS AG (CH) 2009-11-19 WO disclosed